Study Purpose: To formulate recommendations about clinical management of liver
involvement in hereditary hemorrhagic telangiectasia (HHT), using a formal consensus …

Background HHT is an autosomal dominant disease with an estimated prevalence of at least
1/5000 which can frequently be complicated by the presence of clinically significant …

Abstract Hereditary Hemorrhagic Telangiectasia (HHT) is easily recognized in individuals
displaying the classical triad of epistaxis, telangiectasia, and a suitable family history, but the …

Objective Rare diseases may be difficult to study through conventional research methods,
but are amenable to study through certain uncommonly used designs. We sought to explain …

Hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular disorder characterized by
dilated vessels and arteriovenous malformations. Phenotypic heterogeneity, such as age of …

Description: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant
disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of …

Objective To study the clinical characteristics andprognosis of patients with diffuse
pulmonary arteriovenousmalformations (AVMs). Design Retrospective chartreview of all …

Juvenile polyposis (JP) and hereditary hemorrhagic telangiectasia (HHT) are clinically
distinct diseases caused by mutations in SMAD4 and BMPR1A (for JP) and endoglin and …

Hepatopulmonary syndrome (HPS) is present in 10–32% of chronic liver disease patients,
carries a poor prognosis and is treatable by liver transplantation (LT). Previous reports have …

Importance Epistaxis is a major factor negatively affecting quality of life in patients with
hereditary hemorrhagic telangiectasia (HHT; also known as Osler-Weber-Rendu disease) …